| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | NEUTRAL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.54▼ | 3.58▼ | 3.58▼ | 3.26▲ | 3.26▲ |
| MA10 | 3.64▼ | 3.70▼ | 3.69▼ | 3.21▲ | 4.28▼ |
| MA20 | 3.64▼ | 3.37▲ | 3.33▲ | 3.21▲ | 6.05▼ |
| MA50 | 3.30▲ | 3.25▲ | 3.24▲ | 4.64▼ | 20.58▼ |
| MA100 | 3.33▲ | 3.66▼ | 3.88▼ | 6.31▼ | 28.47▼ |
| MA200 | 4.24▼ | 5.27▼ | 5.62▼ | 15.09▼ | 35.64▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.045▼ | 0.007▲ | 0.021▲ | 0.160▲ | 0.618▲ |
| RSI | 50.522▲ | 53.592▲ | 53.994▲ | 47.137▼ | 27.220▼ |
| STOCH | 12.699▼ | 42.195 | 50.802 | 40.517 | 6.660▼ |
| WILL %R | -87.500▼ | -45.294 | -32.083 | -32.143 | -84.567▼ |
| CCI | -88.701 | -30.863 | -3.224 | 132.992▲ | -64.824 |
|
Tuesday, November 10, 2026 03:49 PM
SYDNEY, AUSTRALIA, Nov. 11, 2026 (GLOBE NEWSWIRE) -- (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today announced the grant of a ...
|
|
Tuesday, November 10, 2026 09:09 AM
First survival data from EFTISARC-NEO, released in CTOS 2026 Abstract, demonstrate encouraging preliminary long-term outcomes in patients with resectable soft tissue sarcoma (STS).
|
|
Sunday, November 08, 2026 02:34 PM
Statistically significant and exposure-dependent inhibition of T-cell-driven immune responses in healthy volunteers, with greater pharmacodynamic effects at higher IMP761 exposureWell tolerated across ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/26 | 3.52 | 3.59 | 3.46 | 3.515 | 78,445 |
| 09/11/26 | 3.62 | 3.92 | 3.6068 | 3.80 | 65,950 |
| 06/11/26 | 2.69 | 3.49 | 2.69 | 3.34 | 97,169 |
| 05/11/26 | 2.95 | 2.995 | 2.66 | 2.69 | 16,710 |
| 04/11/26 | 3.01 | 3.035 | 2.93 | 2.95 | 5,450 |
| 03/11/26 | 3.03 | 3.12 | 2.985 | 2.995 | 12,173 |
| 02/11/26 | 3.10 | 3.1113 | 3.00 | 3.07 | 11,625 |
| 30/10/26 | 3.30 | 3.30 | 3.05 | 3.06 | 10,591 |
| 29/10/26 | 3.04 | 3.55 | 3.04 | 3.33 | 14,038 |
| 28/10/26 | 3.19 | 3.46 | 3.19 | 3.32 | 29,526 |
|
|
||||
|
|
||||
|
|